DE69128780D1 - Verwendung von adenosine und adenosinederivate zur anästhesie - Google Patents

Verwendung von adenosine und adenosinederivate zur anästhesie

Info

Publication number
DE69128780D1
DE69128780D1 DE69128780T DE69128780T DE69128780D1 DE 69128780 D1 DE69128780 D1 DE 69128780D1 DE 69128780 T DE69128780 T DE 69128780T DE 69128780 T DE69128780 T DE 69128780T DE 69128780 D1 DE69128780 D1 DE 69128780D1
Authority
DE
Germany
Prior art keywords
adenosine
anesthesia
derivatives
analgesia
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69128780T
Other languages
English (en)
Other versions
DE69128780T2 (de
Inventor
Atsuo F Fukunaga
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24077105&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69128780(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Publication of DE69128780D1 publication Critical patent/DE69128780D1/de
Application granted granted Critical
Publication of DE69128780T2 publication Critical patent/DE69128780T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DE69128780T 1990-05-10 1991-05-07 Verwendung von adenosine und adenosinederivate zur anästhesie Expired - Lifetime DE69128780T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52152990A 1990-05-10 1990-05-10
PCT/US1991/002951 WO1991016903A2 (en) 1990-05-10 1991-05-07 Use of purine derivatives for anesthesia, analgesia and in vivo organ preservation

Publications (2)

Publication Number Publication Date
DE69128780D1 true DE69128780D1 (de) 1998-02-26
DE69128780T2 DE69128780T2 (de) 1998-08-27

Family

ID=24077105

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69133419T Revoked DE69133419T2 (de) 1990-05-10 1991-05-07 Verwendung von Adenosin und Adenosinderivaten für Analgesia
DE69128780T Expired - Lifetime DE69128780T2 (de) 1990-05-10 1991-05-07 Verwendung von adenosine und adenosinederivate zur anästhesie

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69133419T Revoked DE69133419T2 (de) 1990-05-10 1991-05-07 Verwendung von Adenosin und Adenosinderivaten für Analgesia

Country Status (11)

Country Link
EP (2) EP0527917B2 (de)
JP (1) JP3168025B2 (de)
AT (2) ATE277619T1 (de)
AU (1) AU653341B2 (de)
CA (1) CA2082527C (de)
DE (2) DE69133419T2 (de)
DK (1) DK0527917T3 (de)
ES (1) ES2113884T3 (de)
GR (1) GR3026615T3 (de)
WO (1) WO1991016903A2 (de)
ZA (1) ZA913482B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6110902A (en) * 1997-06-23 2000-08-29 Moehler; Hanns Method for the inhibition of neuronal activity leading to a focal epileptic seizure by local delivery of adenosine
DE20215415U1 (de) * 2002-10-08 2004-02-26 Biotechnologie Gesellschaft Mittelhessen Mbh Wasserlösliche Medikamentenvorstufen von Propofol
DE102010027595A1 (de) * 2010-07-23 2012-01-26 Helmut Vorbrüggen Vermeidung von Ischämie- oder Degenerations-Schäden im Gehirn bei Anwendung von Adenosin-Derivaten

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1172391B (it) * 1983-12-23 1987-06-18 Polifarma Spa Composti tirpeptidici contenenti acido piroglutaminico e triptofano,procedimentio di produzione ed applicazioni terapeutiche
FR2577422B1 (fr) * 1985-02-14 1988-10-28 Roussel Uclaf Association renfermant a titre de principes actifs, un analgesique central et l'adenine ou l'adenosine ou l'un des analogues de l'adenosine

Also Published As

Publication number Publication date
DE69133419T2 (de) 2005-11-17
WO1991016903A3 (en) 1992-05-14
EP0821964A2 (de) 1998-02-04
CA2082527A1 (en) 1991-11-11
AU653341B2 (en) 1994-09-29
ZA913482B (en) 1992-02-26
GR3026615T3 (en) 1998-07-31
JP3168025B2 (ja) 2001-05-21
AU7879491A (en) 1991-11-27
ATE162400T1 (de) 1998-02-15
CA2082527C (en) 1998-07-28
EP0821964B1 (de) 2004-09-29
EP0527917B2 (de) 2006-08-16
DE69133419D1 (de) 2004-11-04
DK0527917T3 (da) 1998-09-14
EP0527917B1 (de) 1998-01-21
WO1991016903A2 (en) 1991-11-14
EP0821964A3 (de) 1998-09-02
JPH0665079A (ja) 1994-03-08
ES2113884T3 (es) 1998-05-16
DE69128780T2 (de) 1998-08-27
EP0527917A1 (de) 1993-02-24
ATE277619T1 (de) 2004-10-15

Similar Documents

Publication Publication Date Title
DE69031791D1 (de) Verfahren zur HCV-Züchtung in Zell-Linien aus B- oder T-Lymphozyten
DE3862974D1 (de) 3'-azido-3'-deoxythymidin-formulierungen mit gesteuerter freigabe.
DE3762563D1 (de) Vorrichtung zur erzeugung von ionen in gasstroemen.
DE3878821D1 (de) Verfahren zur herstellung von polypeptiden in zellfreien translationssystemen.
ES2061791T3 (es) Composicion farmaceutica estabilizada y metodo para producirla.
ATE150487T1 (de) Verfahren zur herstellung von cytidin-diphosphat- cholin
NO970106D0 (no) Oppfangingsanalyser
ATE124412T1 (de) Antivirusderivate von (phosphonmethoxy)methoxy purin/pyrimidin.
DE69327004T2 (de) Pharmazeutische formulierungen mit kontrollierter freigabe von 3'-azido-3'-deoxythymidin und verfahren zur verwendung
ATE162400T1 (de) Verwendung von adenosine und adenosinederivate zur anästhesie
DE69606321T3 (de) Verwendung von 2-Ethylhexyl-alpha-cyano-beta, beta-diphenylacrylat zur Verbesserung der Lichtstabilität von p-Methylbenzylidencampher
DE69414525T2 (de) Differenzverstärkerstufe zur Verwendung in ECL-Bipolarstandardverfahren
ATE168274T1 (de) Verfahren zur inaktivierung von viren, die nicht mit lipidhüllen versehen sind
DE68927651D1 (de) Derivate von Fluorphosphonat-Nukleotiden
DE69535263D1 (de) Angiotensin ii zur verbesserung der befruchtung
DE3667960D1 (de) Verfahren zur herstellung von halogen-magnesium-alanat und dessen verwendung.
DE3768288D1 (de) Artikulator zur simulation von unterkieferbewegungen.
SE8900835D0 (sv) Improvement in or relating to organic compounds
ATE247474T1 (de) Verwendung von inosittriphosphat zur herstellung von arzneimitteln
ATE107509T1 (de) Nusammensetzung mit udpg und anderen antitumormitteln zur behandlung von tumoren.
ATE164160T1 (de) Verfahren zur herstellung von 2-acylamino-6- halogen-purin aus 2,9-diacylguanin
NZ502862A (en) Optically pure camptothecin analogues, optically pure synthesis intermediate and method for preparing same
ATE89604T1 (de) Verfahren zur herstellung von aglykonen von avermectin und sie enthaltende kulturen.
ATA238587A (de) Anordnung zur einbringung von strahlenquellen
ES2004489A4 (es) Gametocidas de piridina.

Legal Events

Date Code Title Description
8363 Opposition against the patent
8366 Restricted maintained after opposition proceedings
8332 No legal effect for de